Ajooni Biotech Share Price
Sector: Food Processing
You have to be logged in to add this to Watchlist.
Login or Register
8.00 +0.15 (1.91%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
7.8
Today’s High
8.2
52 Week Low
4.06
52 Week High
10.34
Key Metrics
- Market Cap (In Cr) 135.21
- Beta 1.49
- Div. Yield (%) 0
- P/B 1.83
- TTM P/E 24.79
- Peg Ratio 1.16
- Sector P/E 26.2
- D/E -
Ajooni Biotech Analysis
Price Analysis
-
1 Week9.33%
-
3 Months13.28%
-
6 Month24.6%
-
YTD39.12%
-
1 Year85.49%
Ajooni Biotech Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 80.11
- Selling/ General/ Admin Expenses Total
- 1.8
- Depreciation/ Amortization
- 0.87
- Other Operating Expenses Total
- 5.73
- Total Operating Expense
- 78.75
- Operating Income
- 1.36
- Net Income Before Taxes
- 3
- Net Income
- 2.16
- Diluted Normalized EPS
- 0.22
- Period
- 2024
- Total Assets
- 47.52
- Total Liabilities
- 4.81
- Total Equity
- 42.71
- Tangible Book Valueper Share Common Eq
- 21.49
- Period
- 2024
- Cashfrom Operating Activities
- -3.95
- Cashfrom Investing Activities
- 7.64
- Cashfrom Financing Activities
- -3.57
- Net Changein Cash
- 0.12
- Period
- 2023
- Total Revenue
- 74.49
- Selling/ General/ Admin Expenses Total
- 4.99
- Depreciation/ Amortization
- 1
- Other Operating Expenses Total
- 0.99
- Total Operating Expense
- 72.73
- Operating Income
- 1.76
- Net Income Before Taxes
- 1.58
- Net Income
- 1.12
- Diluted Normalized EPS
- 0.11
- Period
- 2023
- Total Assets
- 58.73
- Total Liabilities
- 17.06
- Total Equity
- 41.67
- Tangible Book Valueper Share Common Eq
- 4.19
- Period
- 2023
- Cashfrom Operating Activities
- -5.58
- Cashfrom Investing Activities
- -15.82
- Cashfrom Financing Activities
- 21.66
- Net Changein Cash
- 0.25
- Period
- 2022
- Total Revenue
- 74.04
- Selling/ General/ Admin Expenses Total
- 5.47
- Depreciation/ Amortization
- 0.97
- Other Operating Expenses Total
- 1.61
- Total Operating Expense
- 72.06
- Operating Income
- 1.97
- Net Income Before Taxes
- 1.46
- Net Income
- 1.05
- Diluted Normalized EPS
- 0.16
- Period
- 2022
- Total Assets
- 29.02
- Total Liabilities
- 12.64
- Total Equity
- 16.38
- Tangible Book Valueper Share Common Eq
- 2.55
- Period
- 2022
- Cashfrom Operating Activities
- 3.68
- Cashfrom Investing Activities
- -1.9
- Cashfrom Financing Activities
- -1.97
- Net Changein Cash
- -0.19
- Period
- 2021
- Total Revenue
- 51.04
- Selling/ General/ Admin Expenses Total
- 5.17
- Depreciation/ Amortization
- 0.44
- Other Operating Expenses Total
- 1.34
- Total Operating Expense
- 49.97
- Operating Income
- 1.07
- Net Income Before Taxes
- 0.5
- Net Income
- 0.37
- Diluted Normalized EPS
- 0.06
- Period
- 2021
- Total Assets
- 28.03
- Total Liabilities
- 12.38
- Total Equity
- 15.65
- Tangible Book Valueper Share Common Eq
- 2.43
- Period
- 2021
- Cashfrom Operating Activities
- 1.16
- Cashfrom Investing Activities
- -3.41
- Cashfrom Financing Activities
- 2.37
- Net Changein Cash
- 0.12
- Period
- 2020
- Total Revenue
- 40.03
- Selling/ General/ Admin Expenses Total
- 3.17
- Depreciation/ Amortization
- 0.35
- Other Operating Expenses Total
- 0.85
- Total Operating Expense
- 39.28
- Operating Income
- 0.75
- Net Income Before Taxes
- 0.48
- Net Income
- 0.35
- Diluted Normalized EPS
- 0.05
- Period
- 2020
- Total Assets
- 23.07
- Total Liabilities
- 7.18
- Total Equity
- 15.89
- Tangible Book Valueper Share Common Eq
- 2.65
- Period
- 2020
- Cashfrom Operating Activities
- -4.38
- Cashfrom Investing Activities
- 0.47
- Cashfrom Financing Activities
- 3.3
- Net Changein Cash
- -0.61
- Period
- 2019
- Total Revenue
- 39.72
- Selling/ General/ Admin Expenses Total
- 0.72
- Depreciation/ Amortization
- 0.3
- Other Operating Expenses Total
- 1.98
- Total Operating Expense
- 39.47
- Operating Income
- 0.24
- Net Income Before Taxes
- 0.47
- Net Income
- 0.41
- Diluted Normalized EPS
- 0.09
- Period
- 2019
- Total Assets
- 18.25
- Total Liabilities
- 6.09
- Total Equity
- 12.16
- Tangible Book Valueper Share Common Eq
- 2.77
- Period
- 2019
- Cashfrom Operating Activities
- -2.79
- Cashfrom Investing Activities
- -0.65
- Cashfrom Financing Activities
- -1.12
- Net Changein Cash
- -4.57
- Period
- 2018
- Total Revenue
- 42.37
- Selling/ General/ Admin Expenses Total
- 0.88
- Depreciation/ Amortization
- 0.31
- Other Operating Expenses Total
- 2.88
- Total Operating Expense
- 41.77
- Operating Income
- 0.61
- Net Income Before Taxes
- 0.49
- Net Income
- 0.39
- Diluted Normalized EPS
- 0.09
- Period
- 2018
- Total Assets
- 19.31
- Total Liabilities
- 8.37
- Total Equity
- 10.94
- Tangible Book Valueper Share Common Eq
- 2.62
- Period
- 2018
- Cashfrom Operating Activities
- -2.64
- Cashfrom Investing Activities
- -0.46
- Cashfrom Financing Activities
- 8.3
- Net Changein Cash
- 5.2
- Period
- 2024-06-30
- Total Revenue
- 25.66
- Selling/ General/ Admin Expenses Total
- 0.57
- Depreciation/ Amortization
- 0.22
- Other Operating Expenses Total
- 1.65
- Total Operating Expense
- 24.92
- Operating Income
- 0.74
- Net Income Before Taxes
- 0.63
- Net Income
- 0.48
- Diluted Normalized EPS
- 0.03
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 19.58
- Selling/ General/ Admin Expenses Total
- 0.14
- Depreciation/ Amortization
- 0.24
- Other Operating Expenses Total
- 2.37
- Total Operating Expense
- 18.23
- Operating Income
- 1.35
- Net Income Before Taxes
- 1.5
- Net Income
- 0.91
- Diluted Normalized EPS
- 0.09
- Period
- 2024-03-31
- Total Assets
- 47.52
- Total Liabilities
- 4.81
- Total Equity
- 42.71
- Tangible Book Valueper Share Common Eq
- 21.49
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -3.95
- Cashfrom Investing Activities
- 7.64
- Cashfrom Financing Activities
- -3.57
- Net Changein Cash
- 0.12
- Period
- 2023-12-31
- Total Revenue
- 20.05
- Selling/ General/ Admin Expenses Total
- 0.61
- Depreciation/ Amortization
- 0.21
- Other Operating Expenses Total
- 1.66
- Total Operating Expense
- 20.92
- Operating Income
- -0.87
- Net Income Before Taxes
- 0.58
- Net Income
- 0.44
- Diluted Normalized EPS
- 0.04
- Period
- 2023-12-31
- Total Assets
- 58.67
- Total Liabilities
- 17.53
- Total Equity
- 41.14
- Tangible Book Valueper Share Common Eq
- 4.14
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 19.48
- Selling/ General/ Admin Expenses Total
- 0.51
- Depreciation/ Amortization
- 0.21
- Other Operating Expenses Total
- 0.74
- Total Operating Expense
- 19.06
- Operating Income
- 0.42
- Net Income Before Taxes
- 0.52
- Net Income
- 0.39
- Diluted Normalized EPS
- 0.04
- Period
- 2023-09-30
- Total Assets
- 57.96
- Total Liabilities
- 17.24
- Total Equity
- 40.72
- Tangible Book Valueper Share Common Eq
- 4.1
- Period
- 2023-09-30
- Cashfrom Operating Activities
- -5.97
- Cashfrom Investing Activities
- 3.77
- Cashfrom Financing Activities
- 2.39
- Net Changein Cash
- 0.19
- Period
- 2023-06-30
- Total Revenue
- 21
- Selling/ General/ Admin Expenses Total
- 0.54
- Depreciation/ Amortization
- 0.21
- Other Operating Expenses Total
- 0.97
- Total Operating Expense
- 20.55
- Operating Income
- 0.46
- Net Income Before Taxes
- 0.39
- Net Income
- 0.39
- Diluted Normalized EPS
- 0.04
- Period
- 2023-06-30
- Total Assets
- 54.43
- Total Liabilities
- 13.99
- Total Equity
- 40.44
- Tangible Book Valueper Share Common Eq
- 4.07
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 41.26
- Selling/ General/ Admin Expenses Total
- 3.49
- Depreciation/ Amortization
- 0.24
- Other Operating Expenses Total
- -1.66
- Total Operating Expense
- 40.55
- Operating Income
- 0.71
- Net Income Before Taxes
- 0.85
- Net Income
- 0.54
- Diluted Normalized EPS
- 0.09
- Period
- 2023-03-31
- Total Assets
- 58.73
- Total Liabilities
- 17.06
- Total Equity
- 41.67
- Tangible Book Valueper Share Common Eq
- 4.19
- Period
- 2023-03-31
- Cashfrom Operating Activities
- -5.58
- Cashfrom Investing Activities
- -15.82
- Cashfrom Financing Activities
- 21.66
- Net Changein Cash
- 0.25
- Period
- 2022-12-31
- Total Revenue
- 10.63
- Selling/ General/ Admin Expenses Total
- 0.51
- Depreciation/ Amortization
- 0.26
- Other Operating Expenses Total
- 0.9
- Total Operating Expense
- 10.42
- Operating Income
- 0.21
- Net Income Before Taxes
- 0.11
- Net Income
- 0.11
- Diluted Normalized EPS
- 0.01
- Period
- 2022-12-31
- Total Assets
- 53.69
- Total Liabilities
- 14.37
- Total Equity
- 39.33
- Tangible Book Valueper Share Common Eq
- 3.52
- Period
- 2022-12-31
- Cashfrom Operating Activities
- -0.29
- Cashfrom Investing Activities
- -1.37
- Cashfrom Financing Activities
- 24.34
- Net Changein Cash
- 22.67
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Ajooni Biotech Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- The Peria Karamalai Tea & Produce Company
- 0
- 0
- 0
- 0
- 0
- 167.44
- Kohinoor Foods
- 41.66
- 0.86
- 2.11
- 61.6
- 35.25
- 154.44
- Ajooni Biotech
- 0
- 0
- 0
- 0
- 0
- 135.21
- Dangee Dums
- 0
- 0
- 0
- 0
- 0
- 113.63
- Simbhaoli Sugars
- 23.42
- 0.59
- 2.58
- 38.5
- 21.79
- 96.68
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- The Peria Karamalai Tea & Produce Company
- 211.04
- 0.88
- 1.15
- 3.88
- Kohinoor Foods
- -
- -
- -
- -22.98
- Ajooni Biotech
- 35.61
- 1.83
- 4.32
- 1.58
- Dangee Dums
- -
- 6.97
- -13.7
- -12.36
- Simbhaoli Sugars
- -
- -
- -
- -2.24
Ajooni Biotech Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 13-Nov-24
- Quarterly Results
- 16-Aug-24
- Others
- 09-Aug-24
- Quarterly Results
- 20-May-24
- Audited Results
- 07-Feb-24
- Quarterly Results & Others
- 09-Nov-23
- Quarterly Results
- 03-Aug-23
- Quarterly Results
- 18-May-23
- Audited Results
- 14-Feb-23
- Quarterly Results
- 11-Nov-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 05-Sept-23
- 19-Jul-23
- AGM
- Announced on
- Record Date
- Ex-Bonus
- Description
- 23-Jan-21
- 12-Mar-21
- 10-Mar-21
- Bonus issue in the ratio of 1:9 of Rs. 10/-.
- Ex-Splits
- Old FV
- New FV
- Description
- 07-Oct-22
- 10
- 2
- Stock split from Rs. 10/- to Rs. 2/-.
- Announced on
- Record Date
- Ex-Rights Date
- Ratio
- FV
- Premium
- Description
- 14-Oct-23
- 07-May-24
- 07-May-24
- 1:1
- 2
- 3
- Rights issue of equity shares of Rs. 2/- in the ratio of 1:1 @ premium of Rs. 3/-.
- 02-Aug-21
- 25-Nov-22
- 25-Nov-22
- 29:30
- 2
- 4
- Rights issue of equity shares of Rs. 2/- in the ratio of 29:30 @ premium of Rs. 4/-.
